Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

TRAFFIX logo

A new study called TrAFFix (Trial of Acute Femoral Fracture Fixation) has just opened at  the John Radcliffe Hospital in Oxford. TrAFFix will compare two different methods of fixing breaks of the thigh bone (femur), and will be rolled out across 6 hospitals in England over the next few months.

Participants aged 50 or over, who have a break in the lower part of their thigh bone (femur), may be eligible to take part. The study will help the planning of a future large trial by measuring recruitment, the completion rate of questionnaires, and assessing participant and staff impressions of the research. The future trial will compare differences in quality of life outcome when patients receive one of two common types of fixation.

TrAFFix is funded by the NIHR Health Technology Assessment Programme (Ref: 15/59/22).

Similar stories

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.